Subscribe
About us
Advertise with us

NeuroSens

Menu

Skip to content

Home
Neurology
Psychiatry

Topic: LGS

Clobazam in Lennox-Gastaut syndrome: phase III results

August 29, 2012

Browse by Topic

MS (370)
AD (83)
PD (78)
COVID-19 (58)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)
BIOMARKERS IN MS (33)

MIGRAINE (26)
SCHIZOPHRENIA (25)
EPILEPSY (22)
STROKE (22)
Library (14)
ECTRIMS 2015 (13)
CLINICAL CASES IN MS (12)
AAN 2015 (11)
ECTRIMS 2019 (10)
ECTRIMS 2014 (10)
DEMENTIA (10)
ECTRIMS 2021 (10)
AAN 2014 (9)
ECTRIMS 2013 (9)
MS SEQUENCING (9)
ECTRIMS 2018 (9)
AAN 2013 (9)
PSYCHIATRY (8)
ACTRIMS-ECTRIMS 2020 (7)
AAN 2019 (7)
ECTRIMS 2017 (6)
ECTRIMS 2022 (6)
AAN 2021 (6)
CHARCOT 2013 (6)
ECTRIMS 2016 (5)
ECTRIMS-ACTRIMS 2023 (5)
ANXIETY (5)
AAN 2022 (5)
CCSVI (5)
BIPOLAR (5)
BPD (4)
AAN 2023 (4)
NeuroSound (4)
EAN 2015 (4)
EAN 2022 (3)
ENS 2013 (3)
AAN 2017 (3)
EAN 2023 (3)
PAIN (3)
AAN 2020 (3)
SLEEP (2)
EAN 2020 (2)
CMSC 2023 (2)
NEW DRUGS (2)
SPECIAL REPORT (2)
AAN 2018 (2)
APA 2014 (2)
GUIDELINES (1)
ACTRIMS 2022 (1)
CONCUSSION (1)
ACTRIMS 2023 (1)
LUMBAR PUNCTURE (1)
NEWS IN BRIEF (1)
ECTRIMS (1)
EAN (1)
EAN 2021 (1)
WEST NILE (1)
APA 2016 (1)
ALS (1)
SEIZURE (1)
LGS (1)
hATTR (1)
Dravet syndrome (1)
CIDP (1)
ADDICTION (1)
EAN 2019 (1)
TSC (1)
INSOMNIA (1)
AAN 2016 (1)
BIOMARKERS (0)
EAN 2016 (0)
ECTRIMS 2020 (0)
AAN (0)

View all Topics

Popular Posts

Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
CNS effects of Wegovy (semaglutide) posted on February 28, 2023
Biomarkers after stopping treatment may identify at-risk MS patients posted on November 30, 2023

Copyright 2023 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)

Contact Us Terms and Conditions